Cross References
|
Nucleotide (GenBank) :
EU266566
ITS including 5.8S rRNA gene
Nucleotide (GenBank) :
KU729160
D1/D2 region of 26S rRNA gene
Nucleotide (GenBank) :
AX109678
Sequence 411 from Patent WO0123604.
Nucleotide (GenBank) :
AB006854
Candida albicans gene for CYP51 variant1, complete cds.
|
References
|
Espinel-Ingroff A, et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 30: 3138-3145, 1992. PubMed: 1452697
Pfaller MA, et al. Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. J Clin Microbiol 32: 1650-1653, 1994. PubMed: 7929752
Espinel-Ingroff A, et al. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J Clin Microbiol 33: 3154-3158, 1995. PubMed: 8586692
Liao RS, et al. Assessment of the effect of amphotericin B on the vitality of Candida albicans. Antimicrob. Agents Chemother. 43: 1034-1041, 1999. PubMed: 10223911
Luu LN, et al. Multilocus genotyping indicates that the ability to invade the bloodstream is widespread among Candida albicans isolates. J. Clin. Microbiol. 39: 1657-1660, 2001. PubMed: 11283111
Yang HC, et al. Extrusion of fluorescein diacetate by multidrug-resistant Candida albicans. Mycoses 44: 368-374, 2001. PubMed: 11766100
Hatano K, et al. Antifungal mechanism of FK463 against Candida albicans and Aspergillus fumigatus. J. Antibiot. 55: 219-222, 2002. PubMed: 12003006
Nishimura M, et al. Cell-associated collagenolytic activity by Candida albicans. Mycopathologia 153: 125-128, 2001.
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeast; Approved Guideline. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M44-A2.
Medical microbiology--Susceptibility testing of microbial pathogens to antimicrobial agents -- Part 84: Microdilution; Special requirements for testing of fungi against antifungal agents. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58940-84: 2002, 2002
Niimi K, et al. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity. J. Antimicrob. Chemother. 65(5): 842-852, 2010. PubMed: 20233776
Wang H, et al. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. BMC Microbiol. 9: 167, 2009. PubMed: 19682357
Innings A, et al. Multiplex real-time PCR targeting the RNase P RNA gene for detection and identification of Candida species in blood. J Clin Microbiol 45: 874-880, 2007. PubMed: 17215340
|